skinny.

Latest / Signal and Symptoms Podcast

What FDA's Step Back Means in Building Credibility

The FDA stepped back. Now, organizational governance is the only thing standing between innovation and liability.

At CES 2026, the FDA officially announced it won't regulate wellness devices or Clinical Decision Support tools—removing approval bottlenecks and accelerating innovation. But this regulatory shift transfers responsibility to healthcare organizations themselves. Who builds the frameworks for data management when there's no FDA requirement? How do health systems justify physician time reviewing continuous patient streams without reimbursement pathways? And where does liability fall…

The skinny

The skinny isn't ready yet — notes appear once the transcript is processed.